Trial intelligence / Profile preview

ONO-1101 in Postoperative Tachyarrhythmias

NCT00212654Phase 3Completed

Sponsor
Ono Pharmaceutical
Start
Jun 2001
Primary completion
Apr 2006
Modality
Small Molecules
01

Overview

A Phase 3 trial of pafuramidine in Supraventricular tachycardia (SVT), sponsored by Ono Pharmaceutical. Started Jun 2001; status: completed.

02

Drugs

pafuramidine
03

Conditions

Supraventricular tachycardia (SVT)

Beyond the preview

Go deeper on NCT00212654.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00212654.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call